1Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blind ing necessary[J .Control Clin Trials, 1996,17 ( 1 ) : 1 - 12.
2Ribeiro SM,Braga CB,Peria FM,et al.Effect of Zinc Supplementation on Antioxidant Defenses and Oxidative Stress Markers in Patients Undergoing Chemotherapy for Colorectal Cancer:a Placebo-Controlled,Prospective Randomized Trial[J].Biol Trace Elem Res,2015,1(12):118-120.
3Al-Shamsi HO,Kee BK,Tetzlaff MT,et al.Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer[J].J Gastrointest Oncol,2015,6(3):40-43.
4Simunovic MR,DeNardi FG,Coates AJ,et al.Product analysis and initial reliability testing of the total mesorectal excision-quality assessment instrument[J].Ann Surg Oncol,2014,21(7):2274-2279.
5Vedat Bayoglu I,Yildiz I,Varol U,et al.Comparison of first-line bevacizumab in combination with mFOLFOX6or XELOX in metastatic colorectal cancer[J].J BUON,2015,20(2):460-467.
6Bongiovanni D,Bassetti B,Kupatt C,et al.Role of bone marrow-derived CD133+stem cells in cardiac regeneration:from experimental to clinical trials[J].G Ital Cardiol(Rome),2014,15(6):355-362.
7Hansen M,Nyby S,Eifer M?倠ller J,et al.Intracoronary Injection of CD34-Cells in Chronic Ischemic Heart Failure:7Years Follow-Up of the DanCell Study[J].Cardiology,2014,129(2):69-74.
